• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在中国的一项回顾性队列研究中,Charlson 合并症指数与心力衰竭患者六个月内全因再入院相关。

Charlson Comorbidity Index is correlated with all-cause readmission within six months in patients with heart failure: a retrospective cohort study in China.

机构信息

Emergency Department, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China.

Institute of Geriatrics, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China.

出版信息

BMC Cardiovasc Disord. 2023 Mar 6;23(1):111. doi: 10.1186/s12872-023-03151-9.

DOI:10.1186/s12872-023-03151-9
PMID:36879196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9987074/
Abstract

BACKGROUND

Charlson Comorbidity Index (CCI) is positively associated with all-cause readmission in patients with heart failure (HF) in western countries. However, there is a scarcity of strong scientific evidence supporting the correlation in China. This study aimed at testing this hypothesis in Chinese.   METHODS: We conducted a secondary analysis of 1,946 patients with HF in Zigong Fourth People's Hospital in China between December 2016 to June 2019. Logistic regression models were used to study the hypotheses, with adjustments for the four regression models. We also explore the linear trend and possible nonlinear relationship between CCI and readmission within six months. We further conducted subgroup analysis and tests for interaction to examine the possible interaction between CCI and the endpoint. Additionally, CCI alone and several combinations of variables based on CCI were used to predict the endpoint. Under the curve (AUC), sensitivity and specificity were reported to evaluate the performance of the predicted model.

RESULTS

In the adjusted II model, CCI was an independent prognostic factor for readmission within six months in patients with HF (OR = 1.14, 95% CI: 1.03-1.26, P = 0.011). Trend tests revealed that there was a significant linear trend for the association. A nonlinear association was identified between them and the inflection point of CCI was 1. Subgroup analyses and tests for interaction indicated that cystatin played an interactive role in the association. ROC analysis indicated neither CCI alone nor combinations of variables based on CCI were adequate for prediction.

CONCLUSION

CCI was independently positively correlated with readmission within six months in patients with HF in Chinese population. However, CCI has limited value on predicting readmission within six months in patients with HF.

摘要

背景

在西方国家,Charlson 合并症指数(CCI)与心力衰竭(HF)患者的全因再入院呈正相关。然而,中国缺乏强有力的科学证据支持这一相关性。本研究旨在检验这一假说在中国人群中的相关性。

方法

我们对中国自贡市第四人民医院 2016 年 12 月至 2019 年 6 月期间的 1946 例 HF 患者进行了二次分析。使用逻辑回归模型研究假设,并对四个回归模型进行了调整。我们还探索了 CCI 与 6 个月内再入院之间的线性趋势和可能的非线性关系。我们进一步进行了亚组分析和交互作用检验,以检验 CCI 与终点之间可能的交互作用。此外,还单独使用 CCI 及其基于 CCI 的变量的几种组合来预测终点。报告曲线下面积(AUC)、敏感性和特异性,以评估预测模型的性能。

结果

在调整后的 II 模型中,CCI 是 HF 患者 6 个月内再入院的独立预后因素(OR=1.14,95%CI:1.03-1.26,P=0.011)。趋势检验显示,两者之间存在显著的线性趋势。两者之间存在非线性关联,CCI 的拐点为 1。亚组分析和交互作用检验表明胱抑素在两者之间具有交互作用。ROC 分析表明,CCI 单独或基于 CCI 的变量组合均不能充分预测 6 个月内再入院。

结论

CCI 与中国人群中 HF 患者 6 个月内再入院独立正相关。然而,CCI 对预测 HF 患者 6 个月内再入院的价值有限。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62e9/9987074/010d8b1667bd/12872_2023_3151_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62e9/9987074/e1ea2ef8b6fd/12872_2023_3151_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62e9/9987074/aec47cf12d24/12872_2023_3151_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62e9/9987074/010d8b1667bd/12872_2023_3151_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62e9/9987074/e1ea2ef8b6fd/12872_2023_3151_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62e9/9987074/aec47cf12d24/12872_2023_3151_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62e9/9987074/010d8b1667bd/12872_2023_3151_Fig3_HTML.jpg

相似文献

1
Charlson Comorbidity Index is correlated with all-cause readmission within six months in patients with heart failure: a retrospective cohort study in China.在中国的一项回顾性队列研究中,Charlson 合并症指数与心力衰竭患者六个月内全因再入院相关。
BMC Cardiovasc Disord. 2023 Mar 6;23(1):111. doi: 10.1186/s12872-023-03151-9.
2
The Charlson comorbidity index and short-term readmission in patients with heart failure: A retrospective cohort study.心力衰竭患者的 Charlson 共病指数与短期再入院:一项回顾性队列研究。
Medicine (Baltimore). 2023 Feb 10;102(6):e32953. doi: 10.1097/MD.0000000000032953.
3
Evaluating the performance of the Charlson Comorbidity Index (CCI) in fracture risk prediction and developing a new Charlson Fracture Index (CFI): a register-based cohort study.评估 Charlson 合并症指数 (CCI) 在骨折风险预测中的性能,并开发新的 Charlson 骨折指数 (CFI):一项基于登记的队列研究。
Osteoporos Int. 2022 Mar;33(3):549-561. doi: 10.1007/s00198-021-06293-8. Epub 2022 Jan 6.
4
Association between the Charlson Comorbidity Index and the risk of 30-day unplanned readmission in patients receiving maintenance dialysis.接受维持性透析患者Charlson 合并症指数与 30 天非计划性再入院风险的关系。
BMC Nephrol. 2019 Oct 7;20(1):363. doi: 10.1186/s12882-019-1538-0.
5
Exploring risk factors of short-term readmission in heart failure patients: A cohort study.探讨心力衰竭患者短期再入院的风险因素:一项队列研究。
Front Endocrinol (Lausanne). 2022 Nov 28;13:1024759. doi: 10.3389/fendo.2022.1024759. eCollection 2022.
6
The risk-adjusted Charlson comorbidity index as a new predictor of one-year mortality rate in elderly Chinese patients who underwent hip fracture surgery.风险调整后的 Charlson 合并症指数作为老年髋部骨折手术患者一年死亡率的新预测因子。
Orthop Traumatol Surg Res. 2021 May;107(3):102860. doi: 10.1016/j.otsr.2021.102860. Epub 2021 Feb 17.
7
Cardiac Transitional Care Effectiveness: Does Overall Comorbidity Burden Matter?心脏过渡护理效果:整体合并症负担是否重要?
Am J Med. 2021 Dec;134(12):1506-1513. doi: 10.1016/j.amjmed.2021.06.018. Epub 2021 Jul 14.
8
Association of red cell distribution width with the risk of 3-month readmission in patients with heart failure: A retrospective cohort study.红细胞分布宽度与心力衰竭患者3个月再入院风险的关联:一项回顾性队列研究。
Front Cardiovasc Med. 2023 Mar 7;10:1123905. doi: 10.3389/fcvm.2023.1123905. eCollection 2023.
9
Predictors and etiologies of 30-day readmissions in patients with non-ST-elevation acute coronary syndrome.非 ST 段抬高型急性冠状动脉综合征患者 30 天再入院的预测因素和病因。
Catheter Cardiovasc Interv. 2019 Feb 15;93(3):373-379. doi: 10.1002/ccd.27838. Epub 2018 Oct 2.
10
Association of lactate/albumin ratio with 3-month readmission risk in heart failure patients: a retrospective study.乳酸/白蛋白比值与心力衰竭患者 3 个月再入院风险的相关性:一项回顾性研究。
ESC Heart Fail. 2024 Aug;11(4):2182-2190. doi: 10.1002/ehf2.14788. Epub 2024 Apr 13.

引用本文的文献

1
Influencing factors of 90-day readmission of patients with heart failure based on the MIMIC-IV database.基于MIMIC-IV数据库的心力衰竭患者90天再入院影响因素
J Thorac Dis. 2025 Mar 31;17(3):1207-1216. doi: 10.21037/jtd-24-1738. Epub 2025 Mar 27.
2
Admission prioritization of heart failure patients with multiple comorbidities.患有多种合并症的心力衰竭患者的入院优先级安排
Front Digit Health. 2024 Jul 2;6:1379336. doi: 10.3389/fdgth.2024.1379336. eCollection 2024.
3
Dendrogram of transparent feature importance machine learning statistics to classify associations for heart failure: A reanalysis of a retrospective cohort study of the Medical Information Mart for Intensive Care III (MIMIC-III) database.

本文引用的文献

1
Readmission Risk Prediction Model for Patients with Chronic Heart Failure: A Systematic Review and Meta-Analysis.慢性心力衰竭患者再入院风险预测模型:系统评价与Meta分析
Iran J Public Health. 2022 Jul;51(7):1481-1493. doi: 10.18502/ijph.v51i7.10082.
2
The Influence of Social Isolation and Medical Comorbidities on Geriatric Congestive Heart Failure Hospital Readmissions.社会隔离和合并症对老年充血性心力衰竭患者再入院的影响
Spartan Med Res J. 2017 Aug 24;2(1):5959. doi: 10.51894/001c.5959.
3
Electronic healthcare records and external outcome data for hospitalized patients with heart failure.
基于机器学习的透明特征重要性树状图对心力衰竭关联进行分类:对重症监护信息集市 III (MIMIC-III)数据库回顾性队列研究的重新分析。
PLoS One. 2023 Jul 20;18(7):e0288819. doi: 10.1371/journal.pone.0288819. eCollection 2023.
电子医疗记录和住院心力衰竭患者的外部结局数据。
Sci Data. 2021 Feb 5;8(1):46. doi: 10.1038/s41597-021-00835-9.
4
Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid.合并症在心力衰竭预后中的作用 第 2 部分:慢性肾脏病、血清尿酸升高。
Eur J Prev Cardiol. 2020 Dec;27(2_suppl):35-45. doi: 10.1177/2047487320957793.
5
Role of comorbidities in heart failure prognosis Part I: Anaemia, iron deficiency, diabetes, atrial fibrillation.合并症在心力衰竭预后中的作用 第一部分:贫血、缺铁、糖尿病、心房颤动。
Eur J Prev Cardiol. 2020 Dec;27(2_suppl):27-34. doi: 10.1177/2047487320960288.
6
Corrigendum to 'Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012-2015' [Eur J Heart Fail 2019;21:1329-1337].《中国心力衰竭和左心室功能障碍的患病率:中国高血压调查,2012 - 2015》勘误 [《欧洲心力衰竭杂志》2019年;21:1329 - 1337]
Eur J Heart Fail. 2020 Apr;22(4):759. doi: 10.1002/ejhf.1808.
7
Trends in prevalence of comorbidities in heart failure clinical trials.心力衰竭临床试验中合并症的流行趋势。
Eur J Heart Fail. 2020 Jun;22(6):1032-1042. doi: 10.1002/ejhf.1818. Epub 2020 Apr 15.
8
Use of E-values for addressing confounding in observational studies-an empirical assessment of the literature.使用 E 值解决观察性研究中的混杂问题——文献的实证评估。
Int J Epidemiol. 2020 Oct 1;49(5):1482-1494. doi: 10.1093/ije/dyz261.
9
Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012-2015.中国高血压调查 2012-2015 年:心力衰竭和左心室功能障碍的患病率。
Eur J Heart Fail. 2019 Nov;21(11):1329-1337. doi: 10.1002/ejhf.1629.
10
A descriptive review of variable selection methods in four epidemiologic journals: there is still room for improvement.对四本流行病学杂志中变量选择方法的描述性综述:仍有改进的空间。
Eur J Epidemiol. 2019 Aug;34(8):725-730. doi: 10.1007/s10654-019-00529-y. Epub 2019 Jun 3.